Sia Daneshmand

Sia Daneshmand: 1-year outcomes from SunRISe-1 study shared for NMIBC

Sia Daneshmand, Urologic Oncology Fellowship Director at the University of Southern California and Director of Clinical Research at Keck Medicine of USC, shared a post on X:

“Joe Jacob presenting highly anticipated 1-year durability study from the SunRISe-1 study showing the excellent results. More options soon to be available for our NMIBC.”

Sia Daneshmand: 1-year outcomes from SunRISe-1 study shared for NMIBC

More posts featuring Sia Daneshmand.